January 2021 FDA Recall Testosterone Cypionate by Sun Pharmaceutical Industries Inc
D-0242-2021 - Incorrect Labeling
This Class III drug recall was voluntarily initiated by Sun Pharmaceutical Industries Inc on January 11, 2021 for the product Testosterone Cypionate. The FDA reported the reason for recall as incorrect labeling. The product was distributed Nationwide and the recall is currently terminated.
Recall Number: D-0242-2021
Incorrect Labeling: Incorrect lot number on secondary packaging
01-11-2021
02-03-2021
36,275 cartons
Recall Profile & Regulatory Data
Class III - is a situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences.
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
The firm responsible for the recall.
SUN PHARMACEUTICAL INDUSTRIES INC
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Method by which the firm first notified the public.
Letter
Distribution Pattern About Distribution Pattern
General area of initial distribution.
General area of initial distribution.
Nationwide
11-02-2021
Product Description About Product Description
Full technical description of the product.
Full technical description of the product.
Testosterone Cypionate Injection, USP CIII 200mg/ml FOR INTRAMUSCULAR USE ONLY 1mL Single-dose vial Distributed by: Sun Pharma Ind. Inc, NJ 08512 Manufactured by: Sun Pharma Ind. Ltd., India NDC 62756-015-40
Batch or Lot Expiration Information
Lot# Lot JKX2553A